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Trichoplein binds PCM1 and controls endothelial
cell function by regulating autophagy
Andrea Martello1, Angela Lauriola2, David Mellis1, Elisa Parish1, John C Dawson3, Lisa Imrie4,
Martina Vidmar1, Noor Gammoh3 , Tijana Mitic1, Mairi Brittan1, Nicholas L Mills1,5,
Neil O Carragher3, Domenico D’Arca2,* & Andrea Caporali1,**
Abstract
Autophagy is an essential cellular quality control process that has
emerged as a critical one for vascular homeostasis. Here, we show
that trichoplein (TCHP) links autophagy with endothelial cell (EC)
function. TCHP localizes to centriolar satellites, where it binds and
stabilizes PCM1. Loss of TCHP leads to delocalization and protea-
some-dependent degradation of PCM1, further resulting in degra-
dation of PCM1’s binding partner GABARAP. Autophagic flux under
basal conditions is impaired in THCP-depleted ECs, and SQSTM1/
p62 (p62) accumulates. We further show that TCHP promotes
autophagosome maturation and efficient clearance of p62 within
lysosomes, without affecting their degradative capacity. Reduced
TCHP and high p62 levels are detected in primary ECs from
patients with coronary artery disease. This phenotype correlates
with impaired EC function and can be ameliorated by NF-jB inhi-
bition. Moreover, Tchp knock-out mice accumulate of p62 in the
heart and cardiac vessels correlating with reduced cardiac vascu-
larization. Taken together, our data reveal that TCHP regulates
endothelial cell function via an autophagy-mediated mechanism.
Keywords autophagy; centriolar satellites; endothelial cells; GABARAP;
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Introduction
Autophagy is an essential quality control function for the cell to
maintain its homeostasis, through selectively degrading harmful
protein aggregates or damaged organelles. Moreover, autophagy is a
vital intracellular process for recycling nutrients and generating
energy for maintenance of cell viability in most tissues and adverse
conditions [1]. Basal autophagy mediates proper cardiovascular
function [2]. Variety of cardiovascular risk factors can cause defec-
tive autophagy in vascular cells, producing high levels of metabolic
stress and impairing the functionality of endothelial cells (ECs) [3].
Autophagy has been shown to regulate angiogenic activity and the
release of von Willebrand factor from ECs [4]. Also, endothelial-
specific deficiency of autophagy is pro-inflammatory and pro-senes-
cent, as it promoted atherogenic phenotype in a murine model of
atherosclerosis [5].
Specific autophagic receptors are responsible for selective autop-
hagy by tethering cargo to the site of autophagosomal engulfment
[6]. The recognition of ubiquitinated substrates is provided by
molecular adaptors including p62/SQSTM1 (p62), which bind on
one side to ubiquitin and, on the other end, to autophagosome-
specific proteins (like members of the LC3/GABARAP/Gate16
family). The interaction between p62 and LC3/GABARAP bridges
the autophagic machinery with its cargo, thereby fostering the selec-
tive engulfment by the autophagosome [7]. In mammalian cells, six
ATG8 orthologues exist that are divided into the LC3 and GABARAP
subfamilies which have a non-redundant function during
autophagosome biogenesis. Specifically, LC3 subfamily members
promote elongation of phagophore membranes, whereas GABARAP
is critical in the closure of the phagophore membrane [8], and
fusion of autophagosomes with lysosomes [9]. Recent studies
demonstrated that a pool of GABARAP exists in the centrosome and
peri-centrosomal region and regulates autophagosome formation
during amino acid starvation [10].
The levels of p62 are regulated transcriptionally and through
continuous degradation during basal autophagy. The defective
autophagy, however, induces accumulation of p62, followed by
the formation of aggregates [11]. Accumulation of p62 is further
observed in human ECs in the cerebral cavernous malformation
disease [12] and in human smooth muscle cells whereby p62
accumulation accelerated the development of stress-induced
premature senescence [13]. Besides its role in autophagy, p62 is a
scaffolding hub for the cellular signalling pathways involving NF-
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kB activation, nerve growth factor signalling and caspase
activation [14].
Trichoplein (TCHP) is cytosolic ubiquitously expressed 62 kDa
protein identified as a keratin filament binding protein [15]. So far,
the function of TCHP is deemed dependent on its partner proteins
and their cellular localization. In proliferating cells, TCHP serves as
a scaffold protein not only for appendage-associated Ninein,
involved in microtubule anchoring at the mother centriole [16], but
also for the centriole-associated Aurora kinase A activity, implicated
in the destabilization of cilia [17]. Alternatively, in differentiated,
non-dividing epithelial cells, TCHP translocates from the centrioles
to keratin filaments, and desmosomes [15]. TCHP was reported to
reside on the outer mitochondrial membrane (OMM), where it binds
mitofusin2 (Mfn2), regulating the ER–mitochondria tethering and
promoting mitochondria fission [18,19]. Moreover, increased levels
of TCHP enable decorin evoked mitophagy [20].
It is still unknown what role TCHP plays in EC function, particu-
larly regarding its localization and mechanisms of action. We report
here that TCHP localizes in centriolar satellites and it has an unex-
pected role in controlling autophagy in ECs.
Results and Discussion
Lack of TCHP impairs endothelial cell function
Accumulating evidence links the intact autophagic responses with
the preservation of cardiovascular homeostasis in several physiolog-
ical and pathological settings [21].
To examine the impact of TCHP on endothelial function, we
performed a Matrigel tubule formation assay. TCHP down-regulation
(Fig EV1A) severely affected the tubule forming capacity of HUVECs
in vitro (Fig EV1B) and the formation of vessels in vivo using Matrigel
plugs (Fig EV1C). In agreement, a reduced level of TCHP also affects
ECs migration as measured in the wound healing (Fig EV1D). To
further dissect the phenotype of ECs lacking TCHP, we analysed the
expression of a subset of genes controlling angiogenesis, inflammation
and cell cycle. TCHP knock-down cells showed an increase of IL1b,
IL6, IL8, MCP1, CDKN2A/p16 and CDNKNB/p14 expression
(Fig EV1E) and displayed a senescent-associated phenotype as seen
by the increase of CDKN2A/p16 (Fig EV1F), b-galactosidase activity
(b-Gal) (Fig EV1G) and the accumulation of aggresomes at 7 days
postlentiviral transduction (Fig EV1H).
TCHP binds PCM1 to regulate its localization
To identify TCHP interacting partners, we performed co-immuno-
precipitation (Co-IP) coupled with mass spectrometry analysis using
FLAG-tagged TCHP as bait in HEK293 cells. The centriolar satellite
protein PCM1 was identified as the most enriched protein in anti-
FLAG pull-down in comparison with the control experiment
(Table EV1 and Appendix Fig S1A). We validated the mass spec-
trometry results showing that in HEK293 cells, two different FLAG-
tagged versions (N- and C- terminal) of TCHP co-immunoprecipi-
tated with endogenous PCM1 (Fig 1A). TCHP displays two coiled-
coil regions, at the N terminus (1–136 AA), which are necessary and
sufficient for centriolar localization and function [22]. Using FLAG-
tagged TCHP deletion mutants (Appendix Fig S1B), we found that
the residues corresponding to the second coiled-coil region (41–136
AA) are critical for the binding to PCM1 (Fig 1B). Moreover, we
demonstrated that the interaction between TCHP and PCM1 is
conserved in HUVECs since TCHP is co-immunoprecipitated with
endogenous PCM1 (Fig 1C).
Endogenous or expressed TCHP showed a dynamic localization
in cells that could be due to a different repositioning of TCHP during
different cell cycle stages or under the effect of cellular stressor or
stimuli [15,17]. Moreover, THCP localization in different subcellular
compartments may mirror different functional roles played by the
same protein. We next tested the localization of PCM1 and TCHP in
ECs. PCM1 was the first satellite protein identified [23] and is acting
as satellite assembly scaffold for other centriolar satellite proteins
such as Cep290 [24] and Cep72 [25].
We established that TCHP extensively co-localized with PCM1 in
the pericentriolar matrix and satellite region (Fig 1D) and localized
close to the nucleus in the same compartment occupied by the
centriolar satellite proteins CEP290 and CEP72 (Fig 1D). Interest-
ingly, depletion of TCHP had a significant effect on PCM1 localiza-
tion, showing loss of PCM1 accumulation at the perinuclear region
and dispersion throughout the cytoplasm (Fig 1E).
Overall, these data demonstrated for the first time that TCHP
binds PCM1 and localizes in centriolar satellites. During the revision
of this manuscript, an independent study was published reporting
the spatial and proteomic profiling of 22 human satellite proteins
using proximity-dependent biotin identification, including PCM1,
CEP290 and CEP72 [26]. Consistently with these results, this unbi-
ased approach has identified TCHP as part of the centriolar satellite
protein network, directly interacting with PCM1, CEP290 and CEP72.
▸Figure 1. TCHP interacts directly with PCM1.A, B (A) Immunoblot analysis showed HEK293 transfected for 48 h with expression vectors for TCHP, and FLAG-TCHP at N- and C-terminal. (B) Immunoblot analysis
showed HEK293 transfected for 48 h with expression vectors for TCHP-FLAG C-terminal or constructs with deletions of the coiled-coil domain 1 (TCHP D1) and 2
(TCHP D2), as indicated in the scheme. For (A and B), total lysates were immunoprecipitated with anti-FLAG antibodies, and blots were probed sequentially with
anti-PCM1, anti-FLAG and anti-ACTIN antibodies. IgG light chains are indicated with Red Ponceau staining. The input totals were analysed by parallel
immunoblotting as a control for the level of expression.
C Anti-PCM1 immunoprecipitation from HUVECs cells and TCHP and PCM1 immunoblot.
D Co-localization of TCHP-V5 and centriolar satellite proteins. HUVECs were transduced with TCHP-V5 lentivirus and stained for anti-PCM1, anti-CEP290, anti-CEP72
and anti-V5 antibodies. Scale bars, 25 and 5 lm in the inset. Right panel: the two-channel intensity correlation of pixels corresponding to regions identified with
TCHP-V5 and satellite markers (n = 90 cells; Pearson co-localization coefficient).
E TCHP knock-down or control cells were stained for anti-PCM1 antibody. Panel below: quantification (n = 50 cells; unpaired t-test; **P = 0.004 vs. control). Scale
bars, 50 and 5 lm in the inset.
Data information: Statistical analyses were performed on at least three independent experiments. Data are represented as mean  SD.
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TCHP regulates PCM1 and GABARAP stability
Since the constant turnover of PCM1 is regulated by the proteolytic
degradation [27], we analysed PCM1 protein levels and degradation
rate in the TCHP-depleted cells. Like centrosomes and cytoskeleton-
associated proteins [28], PCM1 was enriched in the Triton X-100
insoluble fraction, and TCHP depletion reduced PCM1 at the steady
state (Fig 2A). Next, we used cycloheximide (CHX) and MG132 to
block the translation and proteasomal degradation, respectively.
Expression of PCM1 and GABARAP increased in TCHP knock-down
cells compared to the control cells (Appendix Fig S2A and B). In
TCHP-depleted cells treated with CHX, PCM1 protein degradation
was enhanced compared to control cells, while inhibited by MG132,
thus revealing the augmented proteasome-dependent turnover of
PCM1 (Fig 2A).
PCM1 binds directly to GABARAP through a canonical LIR motif
regulating GABARAP-specific autophagosome formation [10].
Although PCM1 depletion did not affect autophagy per se, it has
destabilized GABARAP, but not LC3 [29], through proteasomal
degradation [10]. Recently, the PCM1-GABARAP interaction has
been further dissected through the analysis of the crystal structure
of the PCM1 LIR motif bound to GABARAP, demonstrating that the
manipulation of the key sites in either the PCM1 LIR motif or
sequences flanking the LIR motif can alter the binding specificity of
autophagy adaptors and receptors to ATG8 proteins [30]. The pref-
erence in PCM1 binding might explain the non-redundant functions
of LC3 and GABARAP subfamilies.
GABARAP protein is essential for maturation and expansion [8]
and autophagosome fusion with lysosomes [9]. Accordingly, we
confirmed in ECs, a proteasome-dependent reduction of GABARAP
during the 6 h of treatment with CHX. Without TCHP, in line with
reduced stability of PCM1, the rate of GABARAP degradation was
enhanced (Fig 2B). Conversely, ectopic expression of TCHP-V5
increased PCM1 (Fig 2C) and GABARAP protein levels (Fig 2D)
extending their stability. Altogether, these data suggest that TCHP
regulates PCM1 and GABARAP by proteasomal degradation.
Whether TCHP affects the stability of other centriolar satellites
components or whether the loss of TCHP had a more severe effect
on the integrity of centriolar satellites remains to be determined.
TCHP down-regulation impairs autophagic homeostasis
We next set to establish what role TCHP plays in autophagy. Trans-
mission electron microscope (TEM) revealed a significant increase
in the number of autophagic vesicles when TCHP is depleted in
HUVECs (Fig EV2A).
Alongside the reduction in GABARAP, immunocytochemistry
staining revealed an increased number of LC3- and p62-positive
puncta (Fig 3A). We next set to determine the regulation of the
autophagic flux by analysing the levels of p62 and LC3 in basal and
Hank’s buffered (HBSS) starved cells with or without bafilomycin
A1 (BafA1). In a full medium, Western blot analysis confirmed an
increased level of the lipidated form of LC3 (LC3-II) band and an
increase of p62 protein levels in TCHP knock-down cells compared
with control (Fig 3B). When autophagic flux was blocked with
BafA1 at basal conditions, there was a higher accumulation of p62
in the control cells compared with TCHP knock-down cells. On the
other hand, the LC3 lipidation rate increased more in control cell
than in the TCHP knock-down cells after autophagy stimulation.
Finally, the treatment with HBSS re-activated the autophagic flux in
TCHP knock-down cells as demonstrated by substantial degradation
of LC3-II and reduction of p62 (Fig 3B).
The reduced autophagic flux was further analysed using
mCherry-EGFP-LC3 assays as a complementary approach [31]. The
mCherry fluorescence was lower in TCHP knock-down cells
compared with the control, attesting to a decrease in autolysosome
formation and a slower autophagic flux in cells lacking TCHP
(Fig 3C). There was not a significant difference in the percentage or
a total number of mature autolysosomes following starvation in
HBSS medium (Fig 3C). These results were also confirmed by quan-
titative ratiometric flow cytometry analysis showing a decrease in
mCherry/GFP fluorescence ratio in TCHP knock-down cells
compared with the control, while HBSS treatment increased the
ratio in both conditions (Fig 3D).
To further confirm the impairment of autophagic flux in TCHP
knock-down cells, we performed a non-radioactive pulse-chase
protocol using L-azidohomoalanine (AHA) labelling to quantify
long-lived protein degradation during autophagy [32] (Figs 3E and
EV2B). TCHP knock-down cells conserved a substantial amount of
cellular fluorescence intensity as compared with the control sample.
Conversely, after autophagy stimulation, under amino acid starva-
tion for 2 h, both TCHP knock-down and control cells had reduced
fluorescence intensity (Figs 3E and EV2B).
Finally, overexpression of TCHP reduced the basal level of p62 in
ECs and the accumulation of p62 after BafA1 treatment under full
growth medium (Fig 3F) and increased the degradation of p62
during nutrient starvation or treatment with torin-1 (Fig 3F). More-
over, exogenous TCHP partially rescued PCM1 localization in the
centriolar satellites (Fig EV2C) and decreased p62 accumulation in
ECs lacking TCHP (Fig EV2D). In an attempt to validate the rescue
experiments using TCHP mutants, we observed that exogenously
expressed TCHPD1,2, unlike wild-type TCHP or TCHPD1, failed to
co-localize with PCM1, at least in HeLa cells. Moreover, a scattered
PCM1 staining pattern was observed, similar to that seen after TCHP
knock-down. The latter finding would suggest that the TCHPD,1,2
mutant could act as a dominant-negative for TCHP or perhaps other
centriolar satellite proteins. Further studies will be required to eluci-
date the independent role of TCHPD,1,2 mutant in ECs. Overall,
these results demonstrated a reduced autophagic flux in TCHP
knock-down cells. Nevertheless, although the autophagic flux is
reduced in TCHP knock-down cells, stress-induced autophagy
appears to be functional, suggesting that TCHP-dependent reduction
of basal autophagy is reversible and could be pharmacologically re-
activated.
The depletion of TCHP inhibits autophagosome maturation and
efficient delivery of p62 to the lysosomes
Since GABARAP is critical for autophagosome expansion and matura-
tion [9], we performed the proteinase K protection assay [33] to assess
the efficiency of cargo receptor loading during autophagosome
biogenesis and maturation. Autophagic vesicles were isolated by cyto-
plasm differential centrifugation and treated with proteinase K to
determinate the proportion of the cargo receptor p62, and the ATG8
family proteins, LC3 and GABARAP, are not accessible to the protease
because protected within autophagosome. We found that the
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Figure 2. TCHP regulates PCM1 and GABARAP stability.
A, B (A) Control or TCHP knock-down HUVECs were subjected to cycloheximide (CHX) and MG132 treatments for the indicated number of hours before immunoblotting.
PCM1 levels were analysed in the insoluble fraction. Laminin has been used as a loading control. Below panel: quantification of PCM1 degradation (one-way
ANOVA; *P = 0.0180 vs. control time 0). (B) Condition as in (A), Western blot for anti-GABARAP and anti-ACTIN antibodies. Below panel: quantification of GABARAP
degradation (one-way ANOVA; *P = 0.0215 vs. control time 0).
C, D (C) Control or TCHP overexpressing HUVECs were subjected to CHX treatment for the indicated number of hours prior to immunoblotting. Western blot was probed
for anti-PCM1 and anti-V5 antibodies. Laminin has been used as a loading control. (D) Condition as in (C), Western blot was probed for anti-V5, anti-GABARAP and
anti-ACTIN antibodies. Below panels: quantification of (C) (one-way ANOVA; **P < 0.0001 vs. control time 0; ##P = 0.0003 vs. control CHX) and (D) (one-way
ANOVA; **P < 0.0001 vs. control time 0; ##P = 0.0056 vs. control CHX).
Data information: Statistical analyses were performed on at least three independent experiments. Data are represented as mean  SD.
Source data are available online for this figure.
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sensitivity of p62, LC3 and GABARAP to proteinase K was enhanced
by TCHP knock-down in the low-speed pellet (LSP) and high-speed
pellet (HSP) in full medium and after BafA1 treatment (Fig 4A).
We then analysed the structure of autophagosomes in control
and TCHP knock-down cells treated with BafA1 (Fig 4B). Accord-
ingly, with documented roles for ATG8s and in particular GABARAP
family in enlarging autophagosomal membranes [34], we observed
a considerable reduction for the average size of autophagic vesicles
(AVs) and autophagosomes (APs) in TCHP knock-down cells
(Fig 4B).
Since syntaxin 17 (STX17) is localized explicitly at mature
autophagosomes [35], we analysed the recruitment of STX17 to
autophagosome to distinguish unsealed and immature phagophore
from mature autophagosomes. We observed a significant decrease
in the number of cells with double-positive for LC3 and STX17 in
TCHP knock-down cells at the basal condition and after BafA1 treat-
ment (Fig 4C). Moreover, STX17 recruitment to the autophagosome
(LC3/STX17-positive puncta per cells) is disrupted in TCHP knock-
down cells during the BafA1 treatment (Fig 4C).
Collectively, these results demonstrated that TCHP down-regula-
tion impairs basal autophagy leading to the accumulation of unre-
solved autophagosomes. These conclusions, however, do not
exclude possible direct participation of TCHP in autophagosome
maturation. Recent studies in the transition from phagophore to
autophagosome are expanding the number of proteins and molecu-
lar machineries, such as TRAPP [36] and CHAMP2A [37], operating
at the autophagosome closure, highlighting its complexity.
We then examined the subcellular distribution of p62 in ECs
stained for LAMP2, aggregates and ubiquitinated proteins. Knock-
down of TCHP increased the percentage of p62 puncta that were
also negative for LC3 and LAMP2 (Fig EV3A), therefore, and
suggests that TCHP could impair the delivery of p62 to the lysosome
(LAMP2-negative p62 puncta). Finally, in TCHP knock-down cells, a
considerable fraction of p62 puncta failed to co-localize with the
aggregates and ubiquitinated proteins (Fig EV3B and C).
Lack of TCHP affects lysosome distribution but not the
lysosomal activity
Although we observed that lack of TCHP affected autophagic flux
and autophagosome maturation, we then analysed whether the lyso-
somes activity or distribution are compromised in TCHP knock-
down cells.
Immunostaining demonstrated a discrete alteration in shape, distri-
bution and intensity of RAB11, EEA1 and RAB7 vesicles (Fig EV4A).
Besides, knock-down of TCHP altered the cellular positioning of lyso-
somes as shown by LAMP2 immunolabelling, inducing a marked
perinuclear clustering of these organelles. Further, increased intensity
of LysoTracker RedTM in TCHP knock-down cells suggested increased
acidification and activity of lysosomes (Fig EV4B).
We then performed the epidermal growth factor (EGF) receptor
(EGFR) degradation assay to analyse lysosome activity [38]. Endo-
cytosis and subsequent lysosomal-mediated degradation are the
primary regulators of EGFR stability following ligand activation. Cell
stimulation with EGF upon knock-down of TCHP resulted in an
increasing degradation of EGFR compared with control (Fig EV4C).
We then analysed the lysosome distribution and microtubule
(MT) network in TCHP knock-down cells and control cells during
◀ Figure 3. Analysis of autophagy in TCHP-depleted endothelial cells.A Immunofluorescent staining for LC3 and p62 in TCHP knock-down and control cells. Scale bars, 25 lm. Lower panel: quantification (n = 90 cells, unpaired t-test; LC3:
**P < 0.0001 vs. control; p62: **P < 0.0001 vs. control).
B Western blot of p62 and LC3 during under normal culture condition or starved condition (HBSS) or the presence of BafA1 (2 h) in TCHP knock-down or control cells.
Lower panels: p62 quantification (one-way ANOVA; **P = 0.0003 vs. control, ##P = 0.0093 vs. shTCHP) and LC3 quantification (one-way ANOVA; **P = 0.0008 vs.
control, ##P = 0.0011 vs. shTCHP).
C HUVECs were transduced with the tandem mCherry-EGFP-LC3 and with shRNA TCHP or control vectors. Left panels: representative picture of mCherrry-EGFP-LC3
reporters. Scale bars, 25 lm. Right panel: quantification of the number of mCherry-only (red bars, autolysosomes) or double-positive (mCherry+/EGFP+; yellow bars,
autophagosomes) (n = 80 cells, one-way ANOVA; *P = 0.0447 vs. control; ##P = 0.0007 vs. shTCHP).
D Ratiometric flow cytometric analysis of mCherrry-EGFP-LC3 reporters as in C (one-way ANOVA; *P = 0.0247 vs. control; ##P = 0.0088 vs. shTCHP).
E Quantification of long-lived protein degradation assay in TCHP knock-down and control cells by flow cytometry (one-way ANOVA; **P = 0.0018 vs. control,
##P < 0.0001 vs. shTCHP).
F HUVECs were transduced with TCHP-V5 and control vectors. Western blot for anti-V5 and anti-p62 antibody during under normal culture condition or HBSS or BafA1
or torin-1 treatment. Lower panel: quantification (one-way ANOVA; **P = 0.0044; #P = 0.0117 vs. TCHP-V5).
Data information: Statistical analyses were performed on at least three independent experiments. Data are represented as mean  SD.
▸Figure 4. TCHP contributes to autophagosome maturation.A The postnuclear fraction (PNS) from TCHP knock-down and control HUVECs in the presence or absence of BafA1 was separated into (low-speed pellet) LSP and (high-
speed pellet) HSP fractions and then analysed by immunoblots using anti p62, LC3 and GABARAP antibodies. The sub-fractions were treated with proteinase K (Prot.
K) with or without Triton X-100 (TX-100). Quantification of the Western blot: the p62, LC3 and GABARAP levels relative to respective GAPDH were quantified using
densitometry analysis and normalized to the value of non-treated samples.
B Representative TEM images of autophagosomes in control and TCHP knock-down HUVECs in the complete medium after 3-h incubation with BafA1 (scale bars,
600 nm): (i), quantification of mean autophagic vesicles (AVs) and autophagosome (APs) area and (ii), distribution of the cross-section areas of the analysed vesicles
expressed in percentage (n = 7 cells; > 100 vesicles per sample; AVs: unpaired t-test; **P < 0.0001 vs. control; APs: unpaired t-test **P < 0.0001 vs. control).
C Left panels: representative single-channel and merged images of HUVECs expressing GFP-LC3 and immunostained for STX17. Scale bars, 25 and 2 lm in the inset.
Right panels: quantification of LC3/STX17-positive cells in the presence or absence of BafA1 (one-way ANOVA; **P = 0.0060 vs. control; #P = 0.0136 vs. control BafA1)
and quantification LC3/STX17-positive puncta per cells (n = 50 cells; one-way ANOVA; **P < 0.0001 vs. shTCHP BafA1).
Data information: Statistical analyses were performed on at least three independent experiments. Data are represented as mean  SD.
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starvation (endothelial basal medium without FBS) and recovery
(replenishment of serum). Analysis of lysosome distribution showed
that, in control cells, the starvation increased the proportion of cells
with predominantly perinuclear lysosomes, while upon recovery,
LAMP2-positive vesicles localized at the cell periphery (Fig EV4D).
On the contrary, TCHP knock-down cells showed that the perinu-
clear distribution of lysosome in growing condition (full medium) is
not changed during starvation or recovery conditions (Fig EV4D).
Previous studies reported that TCHP is required for functional MT
anchoring to the centrosome [16]. As expected, TCHP knock-down
cells showed an unfocused MT network in growing conditions
which it is not modulated by starvation (Fig EV4D). Altogether, our
results have revealed that the loss of TCHP inhibits the lysosome
distribution progressively without substantially changing the lysoso-
mal acidity and activity. Finally, p62 level in TCHP knock-down
cells decreased in serum starvation conditions as in control cells
(Fig EV4E), confirming that in TCHP knock-down cells, the autop-
hagic process is not affected by the limited mobility of lysosomes
and the defective MT network.
NF-jB inhibition reduces p62 accumulation, restoring endothelial
cell function
To elucidate the mechanisms behind the accumulation of p62 in
ECs, we have developed a phenotypic screening assay to select
compounds, which could decrease the accumulation of p62 in
ECs lacking TCHP. We screened a library of 176 target-annotated
compounds (including protease, epigenetics and kinase inhibitors)
at two different doses (0.3 and 3.3 lM) with the primary outcome
to reduce the number of p62 cytoplasmic puncta (Appendix Fig
S3A and B). The screen generated a list of 25 hits (Table EV2)
with the top ones being excluded due to high toxicity (apicidin
and terreic acid) or negative effect on endothelial function (splito-
micin) [39]. The screen identified BAY11-7082 (IKK inhibitor),
TYRPHOSTIN AG1288 (tyrosine kinases inhibitor) and SB202190
(p38MAPK inhibitor) as having a definite effect on reducing p62
accumulation in TCHP knock-down cells (Fig EV5A); named
compounds were further tested in secondary functional assays.
BAY11-7082 was the only compound that was able to reduce
cytokine transcription (Fig EV5B) and restore migratory capacity
in TCHP knock-down ECs (Fig EV5C). TCHP knock-down cells
exhibited a marked increase in NF-jB S536 phosphorylation
compared to the control cells. Treatment with BAY11-7082
reduced NF-jB phosphorylation (Fig EV5D) and p62 expression
(Fig EV5E) in TCHP knock-down cells, revealing an NF-jB-depen-
dent contribution to p62 accumulation. As expected, silencing of
NF-jB/p65 reduced p62 expression in ECs lacking TCHP
(Fig EV5F). Since NF-kB response element has been identified in
the p62 promoter [40,41], TCHP knock-down ECs showed an
increased enrichment of NF-jB/p65 on IKBa (as positive control
locus for NF-jB translocation [42]) and p62 promoters by chro-
matin immunoprecipitation (Fig EV5G).
P62 was initially described as a scaffold protein and a signalling
hub for the interactions with many types of enzymes through dif-
ferent binding domains [43]. It is well known also that p62 induces
inflammatory cytokines production via TRAF6 polyubiquitination
and thereby NF-jB activation [44]. Instead, a previous study
demonstrated that stimulated autophagy, by enhanced degradation
of p62, reduced inflammation, whereas blocking autophagy had an
opposite effect [45]. Thus far, the phenotypic screens identified
genes which reduce the accumulation of p62 following stress stim-
uli, as a novel approach to map autophagy pathways [46,47]. While
our screen was designed to identify compounds targeting the accu-
mulation of p62, it is likely that among our hits, we also identified
compounds which regulate autophagy.
Accumulation of p62 in ECs of patients with premature coronary
artery disease and the heart and vessels of Tchp knock-out mice
Accumulation of p62-positive aggregates is among the best-known
characteristics of autophagy-deficient tissues [11]. We analysed the
expression of TCHP, p62 and cytokines in the ECs from patients
with premature coronary artery disease (CAD). The ECs were
obtained from the vessel wall of patients with endothelial dysfunc-
tion, comprising significant impairments in proliferation, adhesion
and migration [48]. Gene expression analysis showed that ECs from
patients express a low level of TCHP and high level of p62 and
cytokines in comparison with the ECs from healthy donors (Fig 5A).
Treatment of ECs from patients with BAY11-7082 has reduced the
accumulation of p62 puncta (Fig 5B) and cytokine expression
(Fig 5C), while it improved their migratory capacity (Fig 5D). Being
that NF-jB is a critical mediator of endothelial cell dysfunction and
impairs vascular regeneration [49], reactivation of autophagy
through inhibition of NF-jB may help to restore vascular function
and reparative angiogenesis.
Heart of Tchp knock-out mice presented a reduced cardiac vascu-
larization with a significant accumulation of p62 in the cardiomy-
ocytes and the vessels (Fig 5E). Finally, p62 accumulated in the
◀ Figure 5. p62 accumulation in ECs from patients with CAD and Tchp knock-out mice.A Expression of TCHP, p62, IL-1b, IL-8 and IL-6 in ECs from vessels wall from patients with CAD (n = 8 patients per group, unpaired t-test; TCHP **P < 0.0001; p62
**P = 0.0007; IL-1b **P < 0.0001; IL-8 **P < 0.0001; and IL-6 **P < 0.0001 vs. healthy subject).
B Staining and quantification of p62 in ECs from healthy subject and patients either treated with vehicle (DMSO) or BAY. Scale bars, 50 lm; (n = 3 patients per group;
n = 80 cells; one-way ANOVA; **P < 0.0001 vs. healthy DMSO; ##P = 0.003 vs. patients DMSO).
C Expression of IL-6, IL-8 and IL-1b (n = 3 patients per group; one-way ANOVA; IL-6: *P = 0.0135 vs. healthy DMSO; #P = 0.0180 vs. patients DMSO; IL-8: *P = 0.0139 vs.
healthy DMSO; ##P = 0.0024 vs. patients DMSO; IL-1b: *P = 0.0104 vs. healthy DMSO; ##P = 0.0069 vs. patients DMSO).
D Migration speed, in ECs from healthy subject and patients either treated with vehicle (DMSO) or BAY (n = 3 patients per group; one-way ANOVA; *P = 0.0325 vs.
healthy DMSO; #P = 0.0336 vs. patients DMSO).
E Left panels: representative images of the heart of wild-type and Tchp knock-out mice stained for CD31 (green) and p62 (magenta). Scale bars, 100 and 50 lm for the
inset. Right panels: quantification of the percentage of cardiac area (n = 4 mice per group; unpaired t-test; **P = 0.083 vs. wild-type) or vessels positive for p62 (n = 4
mice per group; unpaired t-test; **P = 0.058 vs. wild-type) and vessel density (n = 4 mice per group; unpaired t-test; **P = 0.0097 vs. wild-type).
Data information: Data are represented as mean  SD.
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liver and pancreas of Tchp knock-out mice (Appendix Fig S4).
Together, our data ascertain the secure link between depletion of
TCHP, p62 accumulation and vascular function.
In conclusion, these results reveal for the first time the pivotal
role for TCHP in linking EC function with the control of basal autop-
hagy, highlighting a possible novel role in vascular disease.
Materials and Methods
Cells and cell culture and reagents
Human umbilical vein ECs (HUVECs) and ECs from healthy donor
and patients were cultured in EGM-2 (EBM-2 + SingleQuotsTM Kit)
and 2% foetal bovine serum (FBS) (Lonza). HUVECs and ECs were
used between P2 and P6 passages. HEK293T (ATCC) were grown in
Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 g/l glucose,
2 mM L-glutamine, without Na pyruvate (Lonza), 10% FBS and 1%
penicillin/streptomycin (Pen/Strep). Reagents and doses were as
follows: LysoTracker (Thermo Fisher), bafilomycin A1 (Sigma,
200 nM), torin-1 (CST, 10 lM), BAY11-7082 (Abcam, 300 nM),
TYRPHOSTIN AG1288 (Abcam, 300 nM), SB202190 (Tocris,
300 nM), cycloheximide (Sigma, 2 lM) and MG132 (Sigma, 2 lM).
Lentiviral vectors, plasmid constructs and siRNAs
The pLKO DNA plasmids containing the shRNA sequence against
human TCHP were purchased from Sigma-Aldrich (MissionRNAi
TRCN0000127662 and TRCN TRCN0000130868). The scrambled
sequence shRNA plasmid was purchased from Addgene, plasmid
#1864. The packing plasmids used were pCMV-dR8.2 dvpr, plasmid
#8455 and pCMV-VSVG, plasmid #8454 from Addgene. p62-V5
(HsCD00434166), TCHP-V5 (HsCD00444989) and empty vector
(pLX304) are from DNASU plasmid collection, and pBABE-puro
mCherry-EGFP-LC3B (Addgene plasmid # 22418) and pBABEpuro
GFP-LC3 (Addgene plasmid # 22405) were a gift from Jayanta
Debnath. To generate an expression plasmid for 3xFLAG-tagged, the
full-length TCHP coding sequence was amplified by PCR with
primers having the sequence 50-GATGACAAGCTTGGAAACTCCG
AGCCTCAGAGA-30 and 50 GGATCCTCTAGATTCTCTGTACTTATG
GTACCC-30. The PCR product was digested with HindIII and XbaI,
and the resulting DNA fragment was inserted into p3xFLAG-CMV-
7.1 (Sigma) to prepare p3xFLAG-TCHP. A 3xFLAG–TCHP coding
sequence was then amplified by PCR; the products were gel purified
and verified by sequencing. The deletion mutants FLAG-TCHP D1,
lacking the first coiled motif of TCHP protein, and FLAG-TCHP
D1,2, lacking the first and second coiled-coil motives, were gener-
ated by PCR starting from the previously described p3XFLAG-TCHP
full-length construct. The products of the PCR were gel-purified,
verified by sequencing and cloned into the HindIII-XbaI sites of the
p3x-FLAG-CMV-7.1 expression vector.
The primers used in PCR are TCHP D1 Fw_: 50-GCGAT
TAAGCTTTTCAGGATGTCTGACATCTGC-30; TCHP D1.2 Fw_: 50-G
CGATTAAGCTTCAACTTTTGTACGAACACTGG-30; and TCHP Rw_:
50-GGATCCTCTAGATTCTCTGTACTTATGGTACCC-30.
siRNA for NFjBp65 is SMARTpool: ON-TARGETplus RELA
siRNA (Dharmacon), and siRNA for TCHP is SMARTpool: ON-
TARGETplus TCHP siRNA (Dharmacon).
Endothelial cells functional assays
The following functional assays were performed as previously
described [49]: Matrigel assay with HUVECs was performed using
BD Matrigel Basement Membrane Matrix (BD Biosciences). Migra-
tion was analysed with the ECIS machine [ECIS chip array (8W1E)]
(Applied Biophysics). The migration speed was calculated in
micrometres per hour.
Proteinase K protection assay
The subcellular fractionation (PNS; postnuclear supernatant =
300 × g for 5 min at 4°C, LSP; low-speed pellet = 700 × g for 5 min
at 4°C, HSP; high-speed pellet, HSS; high-speed super-
natant = 100,000 × g for 30 min at 4°C) of control of TCHP knock-
down ECs was performed as described in Ref [33]. In brief, each
fraction of LSP and HSP was treated with 100 lg/ml proteinase K
on ice with or without 0.5% Triton X-100 for 30 min. The fraction
samples were precipitated with 10% trichloroacetic acid, washed
with ice-cold acetone three times, resuspended in sample buffer
including 3 M urea and then analysed by Western blot for p62, LC3,
GABARAP and GAPDH antibody. GAPDH was used as a loading
control, as described in Ref [33].
In vivo Matrigel plug assay
Experiments involving mice were covered by the project and
personal licenses issued by the UK Home Office, and they were
performed in accordance with the Guide for the Care and Use of
Laboratory Animals (the Institute of Laboratory Animal Resources,
1996) and in accordance with Animal Research Report of In vivo
Experiments (ARRIVE) guidelines. CD-1 mice (male, 10 weeks old)
were subcutaneously injected into the groin regions with 400 ll
Matrigel containing recombinant mouse basic FGF (PeproTech,
250 ng/ml) and heparin (Sigma, 50 U/ml) mixed with control or
TCHP siRNA (Dharmacon) [lipids (Lipofectamine RNAiMAX
reagent, ratio 1:1 in volume) 5 lg/gel, n = 5 per group]. After
21 days, mice were sacrificed, and the Matrigel plugs were removed
and fixed in 4% paraformaldehyde.
RNA extraction and quantitative real-time analysis
Total RNA was extracted using miReasy kit (Qiagen). For mRNA
analysis, cDNA was amplified by quantitative real-time PCR (qPCR)
and normalized to 18S ribosomal RNA. Each reaction was
performed in triplicate. Quantification was performed by the 2DDCt
method [50]. Primers are from Sigma (KiCqStartTM Primers).
Chromatin immunoprecipitation
Nuclei were isolated from formaldehyde (1% final)-fixed HUVECs
by lysing in ChIP Lysis Buffer [1% SDS, 10 mM EDTA, 50 mM Tris–
HCL (pH 8.1)] supplemented with protease inhibitors. Chromatin
was fragmented by sonication using a Bioruptor UCD-300 ultra-
sound sonicator (Diagenode). DNA-cross-linked proteins were
immunoprecipitated (1% kept as input) using 5 lg of NF-jB/p65
(Millipore) or control mouse IgG antibody. The antibody was pulled
down with protein G beads (Dynabeads, Thermo Fisher) at 4°C
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overnight. Associated DNA was then purified by extraction using
Monarch PCR & DNA Cleanup Kit (New England Biolabs). Immuno-
precipitated DNA and total input were used as a template for real-
time qPCR. ChIP primers for NF-jB/p65 on IjBa promoter are Fw
GTGCGCCCTCAACTAACAGT and Rev CATCCCAATGAAGCTT
CTGA. Identification of the NF-jB/p65 binding sites in the p62
promoter was performed retrieving ENCODE dataset GSM935527
(Chr 5: 179,245,409-179,256,832). Primers for NF-jB/p65 on p62
promoter are Fw CTAAAGATGGCCCAGAGCAG and Rev CCC
CCTCCCAAATAATCCTA.
Mass spectrometric analysis
Gel bands were subjected to overnight trypsin digestion, and peptide
extracts were dried by Speedvac. The dried peptide samples were
resuspended in MS-loading buffer (0.05% trifluoroacetic acid in
water) and then filtered using Millex filter before HPLC-MS analysis.
Nano-ESI-HPLC-MS/MS analysis was performed using an online
system consisting of a nano-pump (Dionex Ultimate 3000, Thermo
Fisher) coupled to a QExactive instrument (Thermo Fisher) with a
precolumn of 300 lm × 5 mm (Acclaim Pepmap, 5 lm particle size)
connected to a column of 75 lm × 50 cm (Acclaim Pepmap, 3 lm
particle size). Samples were analysed on a 90-min gradient in the
data-dependent analysis (1 survey scan at 70k resolution followed
by the top 10 MS/MS). The gradient between solvent A (2% acetoni-
trile in water 0.1% formic acid) and solvent B (80% acetonitrile-20%
water and 0.1% formic acid) was as follows: 7 min with buffer A,
over 1 min increase to 4% buffer B, 57 min increase to 25% buffer
B, over 4 min increase to 35%, over 1 min increase to 98% buffer B
and stay under those conditions for 9 min, switch to 2% buffer B
over 1 min and the column was conditioned for 10 min under those
final conditions. MSMS fragmentation was performed under nitrogen
gas using high energy collision dissociation in the HCD cell. Data
were acquired using Xcalibur ver 3.1.66.10. Data from MS/MS spec-
tra were searched using MASCOT Versions 2.4 (Matrix Science Ltd,
UK) against the human subset of UniProt database with the maxi-
mum missed-cut value set to 2. Following features were used in all
searches: (i) variable methionine oxidation, (ii) fixed cysteine
carbamidomethylation, (iii) precursor mass tolerance of 10 ppm,
(iv) MS/MS tolerance of 0.05 amu, (v) significance threshold (P)
below 0.05 (MudPIT scoring) and (vi) final peptide score of 20.
Progenesis (version 4 Nonlinear Dynamics, UK) was used for LC-MS
label-free quantitation. Only MS/MS peaks with a charge of 2+, 3+ or
4+ were taken into account for the total number of “Feature” (signal
at one particular retention time and m/z), and only the five most
intense spectra per “Feature” were included. Results were exported
using a peptide score cut off of 20. From the exported results sheet,
differentially expressed proteins were considered significant if the P-
value was less than 0.05 and if the number of peptides used in quan-
titation per protein was equal to or more than 2.
Protein network analysis has been performed using STRING soft-
ware (https://string-db.org/).
Phenotypic screening assay
Image acquisition
Plates were imaged on a wide-field Imagexpress Micro XL high
content microscope (Molecular Devices). Images of Hoechst-labelled
nuclei and p62 antibody labelling were imaged using the DAPI and
Cy3 filter sets from 4 different sites within the well using a 20× S
Plan Fluor objective containing up to 200 cells per field of view.
Image analysis
Images were analysed using a custom workflow developed in the
MetaXpress Custom Module Editor (Molecular Devices). A top hat
filter (size = 10 pixels, shape = circle) was applied to remove back-
ground fluorescence from the p62 images. Using the granularity
module, nuclei were first identified in the DAPI image using a user-
defined intensity above local threshold method and maximum
(30 lm) and minimum (10 lm) widths. p62 puncta were then
detected by using a user-defined intensity above local background
and maximum (1 lm) and minimum (0.5 lm) widths. The nuclear
objects were then used as seeds to create a pseudo-whole cell by
growing the mask by 50 pixels. Finally, the nuclear region was
subtracted from the whole-cell mask to give nuclear and cytoplas-
mic masks. The number of p62 puncta in the nuclear and cytoplas-
mic regions was counted per cell.
Data analysis
Data handling and analysis was done using Spotfire High Content
Analyser software (PerkinElmer). Data were aggregated to whole
well averages and were plate normalized to the negative controls by
dividing all values on the plate by the median value for the negative
control and then scaling the values between 0 and infinity, with 1
being the median of the negative controls on that plate. For hit
identification, control cells (no shRNA) were used as positive
controls and an ensemble-based tree classifier was used to identify
hit compounds with a cross-validated fivefold CV misclassification
error of 0.4%. The following features were used in the ensemble-based
tree classifier: Cell_Count;Nuclear_Granules_Nuclear_count_Sum;
Cytoplasmic_Granules_Nuclear_Count_Sum.
Western blot analyses
Total proteins were extracted in RIPA buffer containing 1 mM
sodium orthovanadate and Complete Protease Inhibitor Cocktail
(Roche Applied Science) and quantified using the PierceTM BCA
protein assay kit (Thermo Fisher). Equal amounts of proteins were
loaded onto SDS–polyacrylamide gels and transferred to PVDF
membrane. The membranes were then blocked with 5% non-fat
milk in TBST 0.1% and immunoblotted overnight at 4°C with the
following primary antibodies (1:1,000): TCHP (Santa Cruz Biotech-
nology, SC-515025), b-actin (Sigma, A5441), p62 (GeneTex,
GTX100685), LC3B (CST, #2775), p16 (BD Biosciences, 551154),
NF-jB (Millipore, MAB3026), (S536) NF-jB (CST, #3033), PCM1
(CST, #5213) and GABARAP (CST, #13733), NDP52 (CST, #60732)
and V5 (Thermo Fisher, R960-25). Secondary antibodies (1:5,000):
anti-Mouse IgG–Peroxidase (Sigma, A5906) and anti-Rabbit IgG–
Peroxidase (Sigma, A0545), were incubated for 1 h at RT. Pixel
intensity/quantification was performed using ImageJ.
Immunofluorescence
HUVECs cells were plated on fibronectin-coated glass coverslips.
Twenty-four hours later, the slides were fixed with 4%
paraformaldehyde, permeabilized with 0.05% Triton X-100 in PBS
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and then incubated with the primary antibody (1:400) in 3% BSA
overnight at 4°C. Secondary antibodies diluted 1:1,000 in 3% BSA.
Slides were imaged on Zeiss LSM-780 confocal. Primary and
secondary antibodies used for immunofluorescence were as follows:
PCM1 (CST, #5213), p62 (GeneTex, GTX100685), LC3B (CST,
#2775), Rab7 (CST, #9367), Rab11 (CST, #5589), EEA1 (CST,
#3288), LAMP2 (CST, #49067), STX17 (Proteintech, 17815-1-AP),
CEP290 (Proteintech, 22490-1-AP), CEP72 (Proteintech, 19928-1-
AP) and a-Tubulin (Abcam, ab184613). Aggregates of ECs were
measured using the PROTEOSTAT kit (Enzo Life Science, ENZ-
51035-0025). Senescence of ECs was measured using the Cellular
Senescence Assay Kit from Cell Biolabs, Inc. (Cat: CBA-230).
Imaging analysis
The image analysis software Cell Profiler was used to quantify co-
localization and lysosome distribution. A detailed description of
each stage of the Cell Profiler workflow is located on their website
(http://cellprofiler.org).
Cell profiler workflow for co-localization
The images were processed and subjected to a 20-module co-loca-
lization workflow. To summarize, the images are initially loaded
as separate channels, corrected for light illumination and aligned.
The images then undergo pixel-based correlation, where the pixel
intensities are compared in each image and any initial correlation
determined. The specific structures of interest are determined by
thresholding the images and segmenting them into objects, this
allows for any co-localization to be determined between the indi-
vidual channels and objects of interest. During the final stage of
image analysis, the images are further enhanced, and the objects
of interest are refined. The software then calculates various statis-
tics within the defined regions and calculates the number of
pixels within a specific object in each channel. The area occupied
by co-localized regions is then divided by the area of co-localized
objects of interest and a per image pixel fraction determined from
the total object pixels. This information is then converted into a
percentage co-localization or Pearson correlation and the data
exported.
Cell profiler workflow for lysosome distribution
Radial integrated fluorescence intensity was measured by using
eight concentric circles centred on the nucleus area (each nucleus
then acted as a seed for subsequent 2 lm rings to be draw radiating
from its periphery), thus covering 16 lm radial distribution of indi-
vidual cells. The sum of fluorescence integrated intensity of the
inner four circles was considered as perinuclear and the sum of the
outer four circles as the cytoplasm. Then, the percentage of perinu-
clear localization was calculated by dividing the sum of perinuclear
fluorescence by total fluorescence ([perinuclear/[perinuclear + cyto-
plasm]] × 100). Each treatment was evaluated by quantifying 20
cells per condition and per experiment.
Microtubule density
The intensities of microtubule network were quantified within
manually defined areas tracing the microtubule ends. Images were
imported into ImageJ software where the cell periphery of cells was
identified using a thresholding method. The total pixel density/
mean fluorescence intensity per whole cell after subtraction of the
background was measured and plotted for each condition.
Electron microscopic analysis
Cell pellets were prepared and fixed in 4% paraformaldehyde or
2.5% paraformaldehyde/0.2% glutaraldehyde in 0.1 M phosphate
buffer (pH 7). Pellets were embedded in HM20, 70-nm sections cut
and examined using a Philips CM10 transmission electron micro-
scope equipped with a Gatan Bioscan Camera.
Endothelial cells from patients
The study was performed with the approval of the South-East Scot-
land Research Ethics Committee, in accordance with the Declaration
of Helsinki and with the written informed consent of all participants.
Patients with premature coronary artery disease and a family history
of premature coronary artery disease (n = 8) were identified from
the outpatient department, Royal Infirmary of Edinburgh, Scotland,
UK. A control group of healthy age- and sex-matched subjects
(n = 8) with no evidence of significant coronary artery disease
following computed tomography coronary angiography (CTCA) was
recruited from the Clinical Research Imaging Centre, Royal Infirmary
of Edinburgh. Subjects attended the Clinical Research Facility at the
Royal Infirmary of Edinburgh for vascular assessment and tissue
sampling. Vessel wall endothelial cells were isolated from superficial
forearm veins by wire biopsy for in vitro expansion as reported in
Ref [48]. Briefly, under local anaesthetic, an 18-gauge venous
cannula was inserted into a superficial forearm vein and a J-shaped
guidewire passed and gently manipulated to harvest endothelial
cells. EGM-2 medium was syringed through the wire to detach cells,
which were collected by centrifugation and seeded into BD BioCoat
Collagen 1 coated six-well plates (BD Biosciences). Cells were incu-
bated under standard culture conditions in EGM-2 medium.
Non-radioactive long-lived protein degradation assay
A non-radioactive pulse-chase protocol using L-azidohomoalanine
(AHA) labelling was performed to quantify long-lived protein degra-
dation during autophagy [32]. Cells were cultured in L-methionine-
free medium for 30 min to deplete the intracellular methionine
reserves. Following methionine depletion, the cells were labelled
with AHA 18 h. Dialysed FBS (Thermo Fisher) was used to elimi-
nate L-methionine from this other source. After labelling, the cells
were cultured in regular medium or HBSS containing 10× L-methio-
nine (2 mM) for 4 h to chase out the short-lived proteins. Then,
cells were fixed in 4% formaldehyde in PBS and undergo a “click”
reaction between the azide group of AHA and a fluorescently tagged
alkyne probe (Click-iT AHA; Thermo Fisher, C10102). The
degradation of AHA-containing proteins was then detected by flow
cytometry.
Autophagic flux analysis by quantitative ratiometric
flow cytometry
Cells stably expressing mCherry-GFP-LC3 were used for flow cyto-
metric analysis. Briefly, a BD LSR Fortessa (Beckman Coulter) using
488 and 561 nm lasers for green and red fluorophore excitation,
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respectively, was used to perform flow cytometry. The appropriate
forward/side scatter profile was used to exclude non-viable cells.
Cells undergoing autophagy were defined as those expressing a high
mCherry/GFP fluorescence ratio, since delivery by autophagy to the
lysosome quenches the GFP signal, but not the mCherry signal. The
gates to define what constituted an increased mCherry/GFP fluores-
cence ratio were set based on cells treated with BafA1. The bottom
of the gate for each set of flow cytometry experiments was therefore
set at the rightward base of the BafA1-treated curve.
TCHP knock-out mice tissues and histological analysis
Heart, liver and pancreas tissues are from C57BL/6N-Atm1Brd
Tchptm1b (EUCOMM)Wtsi/WtsiIeg (Tchp knock-out) mice and were kindly
provided from the Wellcome Trust Sanger Institute. Histological
analysis was performed on four wild-type mice (two male and two
female) and four Tchp knock-out mice (two male and two female)
16-week-old.
Paraffin cross-sections were blocked with normal goat serum,
incubated with anti-CD31 (Abcam; 1:200) and anti-p62 (Genetex
1:200) primary antibody overnight at 4°C, and then incubated with
Alexa 488-conjugated anti-rat IgG antibody (Thermo Fisher). High-
power fields were captured (at 400×), and the number of capillaries
and arterioles per field was counted. At least 30 randomly chosen
fields were evaluated per sample, in a blinded experiment. CD31-
positive vessel area was quantified using ImageJ software and
expressed per square micrometres.
Statistical analysis
Comparisons between different conditions were assessed using the
2-tailed Student’s t-test. If the normality test failed, the Mann–
Whitney test was performed. Continuous data are expressed as
mean  SD of at least three independent experiments. P-value <
0.05 was considered statistically significant. Analyses were
performed using GraphPad Prism v5.01.
Data availability
The mass spectrometry proteomics data from this publication have
been deposited to the ProteomeXchange Consortium (http://prote
omecentral.proteomexchange.org) via the PRIDE partner repository
[51] with the dataset identifier PXD015581.
Expanded View for this article is available online.
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